Pos0068 Flare and Drug-Free Remission in Rheumatoid Arthritis - Clinical Predictors From the Bio-Flare Study

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1POS0600 DOSE REDUCTION STRATEGY OF BIOLOGIC DRUGS IN RA PATIENTS IN REMISSION: A MODEL TO PREDICTIVE FLARE2024
2. 2P154 Perceived triggers and preventers of flares in systemic autoimmune rheumatic diseases2026
3. 3OP0021 3-YEAR RESULTS OF TAPERING TNFi TO WITHDRAWAL COMPARED TO STABLE TNFi AMONG RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION: A MULTICENTER RANDOMIZED TRIAL2024
4. 4POS0191 A LUPUS FLARE RISK INDEX INFORMED BY SELECT ADAPTIVE AND TNF SUPERFAMILY IMMUNE MEDIATORS: VALIDATION IN A CONFIRMATORY COHORT2024 · 1 citations
5. 5OA02 Longitudinal high throughput proteomics identifies novel proteins associated with inflammation and future response in new-onset, treatment-naïve rheumatoid arthritis2024